Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ATI Physical Therapy, Inc.ATIP · Entity 79823 | Director | August 20, 2024 | August 22, 2024 |
| Brookdale Senior Living Inc.BKD · Entity 4268 | Interim CFO | March 28, 2018 | April 03, 2018 |
| HARROW, INC.HROW · Entity 4740 | Director | June 21, 2023 | June 23, 2023 |
| InnovAge Holding Corp.INNV · Entity 4693 | Director | July 01, 2026 | July 02, 2026 |
| Surgery Partners, Inc.SGRY · Entity 4534 | Executive VP & CFO | December 31, 2017 | January 03, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ATI Physical Therapy, Inc.
Report date August 20, 2024 · Filed August 22, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2034-08-20 | Direct | 7,974 |
Reported balance
After 2024-08-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-20 · Grant · Acquired 6,255 · Balance 7,974 F1: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.50 · Expires 2034-08-20 | Direct | 14,229 |
Reported balance
After 2024-08-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-20 · Grant · Acquired 6,255 · Balance 14,229 F1: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.00 · Expires 2034-08-20 | Direct | 20,484 |
Reported balance
After 2024-08-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-08-20 · Grant · Acquired 6,255 · Balance 20,484 F1: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.00 · Expires 2034-08-20 | Direct | 32,993 |
Reported balance
After 2024-08-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-08-20 · Grant · Acquired 12,509 · Balance 32,993 F1: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $155.50 · Expires 2031-12-28 | Direct | 649 |
Reported balance
After 2021-12-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-28 · Grant · Acquired 649 · Balance 649 F2: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of December 1, 2021, each subject to the Reporting Person's continued service through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $87.00 · Expires 2032-03-07 | Direct | 1,070 |
Reported balance
After 2022-03-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-03-07 · Grant · Acquired 1,070 · Balance 1,070 F3: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of March 7, 2022, each subject to the Reporting Person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights.
F2: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of December 1, 2021, each subject to the Reporting Person's continued service through the applicable vesting date.
F3: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of March 7, 2022, each subject to the Reporting Person's continued service through the applicable vesting date.
Brookdale Senior Living Inc.
Report date March 28, 2018 · Filed April 03, 2018
This filing explicitly reported no securities owned.
HARROW, INC.
Report date June 21, 2023 · Filed June 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RSUSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,744 |
Reported balance
After 2023-06-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-21 · Grant · Acquired 7,744 · Balance 7,744 F1: The Restricted Stock Units were received as a compensatory award for no consideration. F2: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units were received as a compensatory award for no consideration.
F2: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.
InnovAge Holding Corp.
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 67,665 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 8,539 · Balance 67,665 F1: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.
Surgery Partners, Inc.
Report date December 31, 2017 · Filed January 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 192,360 |
Reported balance
After 2017-12-31 transaction · row 1
1 source rowRow 1 · 2017-12-31 · Tax withholding · Disposed 1,016 · Balance 192,360 F1: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on December 31, 2017 of restricted stock that was delivered to the Reporting Person on March 9, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on December 31, 2017 of restricted stock that was delivered to the Reporting Person on March 9, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 2, 2026 20:32 UTC | InnovAge Holding Corp. INNV · Entity 4693 | GrantCommon Stock, $0.001 par value | 8,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001834376-26-000035 · wk-form4_1783024342.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,665 F1 · shares: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:18 UTC | InnovAge Holding Corp. INNV · Entity 4693 | GrantCommon Stock, $0.001 par value | 25,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001834376-25-000040 · wk-form4_1751487470.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,126 F1 · shares: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 20:31 UTC | InnovAge Holding Corp. INNV · Entity 4693 | GrantCommon Stock, $0.001 par value | 16,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001834376-24-000057 · wk-form4_1725395460.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,810 F1 · kind: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on August 14, 2025, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 19:51 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (Right to Buy) · Derivative | 12,509 | $0.00 Strike: $50.00 | $0.00 |
DisclosureSEC source: 0001140361-24-038289 · form4.xml · derivative · entry 4 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,993 Underlying: Class A Common Stock · 12,509 shares Expires 2034-08-20 F1 · derivative.exercise_date: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 19:51 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (Right to Buy) · Derivative | 6,255 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001140361-24-038289 · form4.xml · derivative · entry 3 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,484 Underlying: Class A Common Stock · 6,255 shares Expires 2034-08-20 F1 · derivative.exercise_date: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 19:51 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (Right to Buy) · Derivative | 6,255 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001140361-24-038289 · form4.xml · derivative · entry 2 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,229 Underlying: Class A Common Stock · 6,255 shares Expires 2034-08-20 F1 · derivative.exercise_date: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 19:51 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (Right to Buy) · Derivative | 6,255 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001140361-24-038289 · form4.xml · derivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,974 Underlying: Class A Common Stock · 6,255 shares Expires 2034-08-20 F1 · derivative.exercise_date: One-third of the Stock Options vest on each of the following dates: April 1, 2025, April 1, 2026, and April 1, 2027, each subject to the Reporting Person's continued service through the applicable vesting date or application of certain vesting acceleration rights. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 22:42 UTC | InnovAge Holding Corp. INNV · Entity 4693 | GrantCommon Stock, $0.001 par value | 17,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-091568 · tm2323192-1_4seq1.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,362 F1 · kind: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on the anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:30 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 7,744 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-022259 · ownership.xml · derivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,744 Underlying: Common Stock · 7,744 shares Expires not disclosed F1 · security: The Restricted Stock Units were received as a compensatory award for no consideration. F2 · derivative.exercise_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · derivative.expiration_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 08:55 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantClass A Common Stock | 294,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-013587 · form4.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,931 F1 · shares: Award of restricted stock units subject to stockholder approval of an amendment to the ATI Physical Therapy Inc.'s 2021 Equity Incentive Plan, under which the restricted stock units were granted. The stockholder approval vote is expected to occur at the Company's 2023 Annual Meeting. Read SEC document |
| March 22, 2023 Filed Mar 27, 2023 14:52 UTC Amendment | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantClass A Common Stock | 294,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-013956 · form4.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,931 F1 · shares: Award of restricted stock units subject to stockholder approval of an amendment to the ATI Physical Therapy Inc.'s 2021 Equity Incentive Plan, under which the restricted stock units were granted. The stockholder approval vote is expected to occur at the Company's 2023 Annual Meeting. F2 · acquired: This amendment is being filed to correct a clerical error in Table I item 4. The securities were acquired and not disposed. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:53 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 13,123 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-016473 · ownership.xml · derivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,123 Underlying: Common Stock · 13,123 shares Expires not disclosed F1 · security: The Restricted Stock Units were received as a compensatory award for no consideration. F2 · derivative.exercise_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · derivative.expiration_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 20:37 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (right to buy) · Derivative | 53,491 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0000899243-22-010339 · doc4.xml · derivative · entry 2 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,905 Underlying: Class A common stock · 53,491 shares Expires 2032-03-07 F1 · derivative.exercise_date: One-third of the Stock Options vest on each of the first three anniversaries of March 7, 2022, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 20:37 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantClass A common stock | 28,736 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-010339 · doc4.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,813 Read SEC document |
| March 07, 2022 Filed Aug 22, 2024 19:51 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (Right to Buy) · Derivative | 1,070 | $0.00 Strike: $87.00 | $0.00 |
DisclosureSEC source: 0001140361-24-038289 · form4.xml · derivative · entry 6 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,070 Underlying: Class A Common Stock · 1,070 shares Expires 2032-03-07 F3 · derivative.exercise_date: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of March 7, 2022, each subject to the Reporting Person's continued service through the applicable vesting date. F3 · balance_after: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of March 7, 2022, each subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 17:28 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (right to buy) · Derivative | 32,414 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0000899243-21-050046 · doc4.xml · derivative · entry 2 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,414 Underlying: Class A common stock · 32,414 shares Expires 2031-12-28 F1 · derivative.exercise_date: One-third of the Stock Options vest on each of the first three anniversaries of December 1, 2021, each subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 17:28 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantClass A common stock | 16,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-050046 · doc4.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,077 Read SEC document |
| December 28, 2021 Filed Aug 22, 2024 19:51 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantStock Option (Right to Buy) · Derivative | 649 | $0.00 Strike: $155.50 | $0.00 |
DisclosureSEC source: 0001140361-24-038289 · form4.xml · derivative · entry 5 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 649 Underlying: Class A Common Stock · 649 shares Expires 2031-12-28 F2 · derivative.exercise_date: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of December 1, 2021, each subject to the Reporting Person's continued service through the applicable vesting date. F2 · balance_after: This Stock Option was adjusted to reflect the reverse stock split that occurred on June 14, 2023. One-third of the Stock Options vest on each of the first three anniversaries of December 1, 2021, each subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 00:54 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 9,644 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-015456 · ownership.xml · derivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,644 Underlying: Common Stock · 9,644 shares Expires not disclosed F1 · security: The Restricted Stock Units were received as a compensatory award for no consideration. F2 · derivative.exercise_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · derivative.expiration_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 22:05 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 17,006 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-010787 · ownership.xml · derivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,006 Underlying: Common Stock · 17,006 shares Expires not disclosed F1 · security: The Restricted Stock Units were received as a compensatory award for no consideration. F2 · derivative.exercise_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · derivative.expiration_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 23:04 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-004289 · ownership.xml · derivative · entry 1 Sparks Teresa · CIK 0001650335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2021-03-16 F1 · security: Award of Restricted Stock Units vests in full on the one-year anniversary from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · security: The Restricted Stock Units were received as a compensatory award for no consideration. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:37 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Tax withholdingCommon Stock | 1,016 | $12.10 | $12,293.60 |
DisclosureSEC source: 0000904454-18-000009 · edgar.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,360 F1 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on December 31, 2017 of restricted stock that was delivered to the Reporting Person on March 9, 2017. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:23 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-17-000294 · edgar.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,376 Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 23:31 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Tax withholdingCommon Stock | 2,838 | $19.90 | $56,476.20 |
DisclosureSEC source: 0000904454-17-000259 · edgar.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,556 F1 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 17, 2017 of restricted stock that was granted to the Reporting Person on March 17, 2016. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 21:56 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 7,427 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-17-000247 · edgar.xml · nonDerivative · entry 1 Sparks Teresa · CIK 0001650335 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,394 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.